Severity
Moderate
FDA Devices recall · Reported September 7, 2022
One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component.
Abbott Laboratories recalled ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27 - a moderate-severity action.
ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27 was recalled by Abbott Laboratories in September 7, 2022. Reason: One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the c…. Check the official notice for the remedy. Verify recall #Z-1660-2022 with the FDA Devices before acting.
The recall
Abbott Laboratories issued this moderate-severity FDA Devices recall-One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the c….
Sourced from official FDA Devices enforcement records. Verify recall #Z-1660-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1660-2022) was formally reported on September 7, 2022, with the manufacturer initiating the action on July 26, 2022. It is classified under Moderate severity (Class II), with a current status of Ongoing. Abbott Laboratories is listed as the recalling firm, operating out of Abbott Park, IL. Federal records list the affected scope as 2451 kits of 100 tests.
The documented reason for this recall is: One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
2451 kits of 100 tests
Related Recalls
6
3 from same agency
ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27
One lot of reagent was manufactured with insufficient quantities of the heterophilic blocking agents in the conjugate component.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | Z-1660-2022 |
| Date reported | September 7, 2022 |
| Date initiated | July 26, 2022 |
| Recalling firm | Abbott Laboratories |
| Firm location | Abbott Park, IL |
| Affected scope | 2451 kits of 100 tests |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported September 7, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.